EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS091-33455 
Organism
Homo sapiens 
Tissue/cell
HepG2 
Coordinate
chr22:50644950-50646650 
Target genes
TF binding sites/motifs
Number: 8             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
HES2MA0616.2chr22:50646404-50646414GGCACGTGCC+6.02
HES2MA0616.2chr22:50646404-50646414GGCACGTGCC-6.02
KLF13MA0657.1chr22:50646302-50646320AGGCCACGCCCCTCCGTG+6.68
KLF14MA0740.1chr22:50646303-50646317GGCCACGCCCCTCC+6.25
SP1MA0079.4chr22:50646301-50646316CAGGCCACGCCCCTC+6.62
SP3MA0746.2chr22:50646303-50646316GGCCACGCCCCTC+6.18
SP4MA0685.1chr22:50646301-50646318CAGGCCACGCCCCTCCG+6.36
ZfxMA0146.2chr22:50646620-50646634GAGGCCGAGGCGGG-6.01
Number of super-enhancer constituents: 3             
IDCoordinateTissue/cell
SE_10100chr22:50644698-50646348CD14
SE_41681chr22:50644711-50645428LNCaP
SE_62001chr22:50612960-50648669Toledo
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr225064576250646486
Number: 1             
IDChromosomeStartEnd
GH22I050205chr225064437750645349
Enhancer Sequence
TAATGCCGGG GGCCTTTCGG CCTGTCTACA CGCACTTGCT TAGAGTCCTA GGAGATTTGG 60
GCCTGTGCTG CTAGGATTCT GGTAGAAACA AACCCAGATG ACCGCCTTGG CCTCTTCTGA 120
AAGTCCAGCC TGTCCCTGGC AGCCTCAGAA GCTGCCTGTC CGCGAAGTAG CTGCGTCACG 180
CCCACTGGGA GGGATCTGAG TGCAAAGGCA TTTGGTACTC AGTTAGGACA CTTGTGCTGA 240
GCCCTCCCAC GTGCCCGGCC AGGCCCTCGT TGCAGCCAGA GATGGCCCTG CGGGAGCTGG 300
TGTGTCTCAA AGCACCAGCA GGGGGCTCCA GGGCCACGGG CACCAGAGAA GGGTCCCTGC 360
CTGGTGCTTC TGGGGGGGAG GGGGTCCCTG AGCCTGAGGC TGGGGACAGT GTCCAGAGCT 420
GTTTGCTGGA GTTTATGACA AGGAACTACT TAGACTTGAC TGAGGAAATG GCCACTGAAG 480
AAGCAGGAGC CGCAAGCTGT GCGCGGTGTC CTGCTCAGGC TTTCTGATCT GATGGTCCAG 540
TTGCTCGTTG GTCTGGAGTC CTAGGCTGGC TCCTGTCTGA CGTGAGCCAT CAGTTATCAG 600
TTCTCTTTTC TTTTTTTTTG AGACAGAGTA TCGCTCTGTC ACCCAGGCTG GAGTGCAGTG 660
GCGTGATCTT GGCTCAGTGC AACCTCCGCC TCCCGGGTTC AAGCGATTCT CCTACCTCAG 720
TCCCCCCAAA TAGCTGGGGT TACAGACGTG CGCCACCACG TCCAGCTAAT TTTTATATTT 780
TTAGTACAGA CAGGGTTTCT CCATGTTGGC CAGGCTGGTC TCGAACTCCT GACCTCTGGT 840
GATTCACCCA TCTTGGCCTC CTAAAGTGCT AGAATTATAG GCCTGAGCCA CCGCGCCCGG 900
CCCCCAGCCA TCAGTTTTTG ATGTCACCTT GCCACCTGGC GTCTAGCACT TCCTCCTGAA 960
CACCTGAATG TAGTTGTCTG TTGGTCTTGC AGCCCCGTCC TGCCCGGGAC ACCAGCCGCC 1020
CACCCCTGAG GCTGCCTGTG GGCCTCTGGC TTTTCCTGTC CTGCAGGGGG ATGGGAAAGA 1080
TCTGGGGCCA CGACTTCCTC TGAGGCCCCG CCCAGCGGCA ATGCTGGCAT TGTTGTGAAG 1140
TCCACCCTGT GTGCACACAG CATCCCTGCC CTGGGCCCGC TGGTTGCCAG TAGTAACCCC 1200
AGTTGTGACA ACGAAAAATG TGTCCAGACC TTGCCTGATG TCCCCTGGGG GGCAGTCACC 1260
CTGGGGGACG GCTGCTGGTG AGCGCTCACA GATGTGTGTC CATAGCAGCT GACTCTCCTT 1320
TGCATCTCCT CCCCGAGGAC GCAGTGGCAG GCAGGCCACG CCCCTCCGTG TGTAAGACCT 1380
GCCGAAAACA CTCCTCGTGG GGTTGGGGTG GGAGTGCAGG GGCCTTGGTG GTTTCTACAC 1440
CCATGGGCCT GCCCGGCACG TGCCCCAGAC TGTGCAGACA GGGCCTGGTC AGTGGCTGGA 1500
TGTTGACCAA ACGTGGAATA TGTCTGTGTG TCAGGTAAAG CTGTGGTGCA TTCTGGTTGG 1560
TTGTTTGCTT TTGTTTTAAT CAAGGTTCTC TTTCTGCTGT AGGGCTGCAT GATTTAGCAG 1620
CCACAACAGG CCAGGCGCGG TGGCTCACGC CTGTAATCCC AGCACTTTGG GAGGCCGAGG 1680
CGGGTGGATC ACGAGGTCAG 1700